Eating Disorders: What Research Shows About Causes, Prevalence, and Treatment

Eating disorders, including anorexia nervosa, bulimia nervosa, binge eating disorder, and avoidant restrictive food intake disorder, are serious psychiatric conditions with significant medical consequences and, in the case of anorexia nervosa, among the highest mortality rates of any mental health condition. Despite their severity, eating disorders have historically been underresearched relative to their burden, partly because they disproportionately affect women and girls and were for decades dismissed as vanity-driven behavior rather than recognized as complex psychiatric conditions. Research over the past two decades has substantially advanced understanding of causes, risk factors, neurobiology, and treatment, though significant gaps remain. Prevalence estimates for eating disorders depend substantially on the diagnostic criteria and assessment methods used. Anorexia nervosa affects approximately one percent of women in their lifetime, with somewhat lower rates in men. Bulimia nervosa affects roughly three to four percent of women. Binge eating disorder, which was formally recognized in DSM-5 in 2013, is more common than anorexia or bulimia, affecting approximately three percent of women and two percent of men at some point in their lives. Other specified and unspecified feeding and eating disorders, which do not meet the full criteria for specific diagnoses, affect additional percentages of the population with varying degrees of severity. Genetic factors contribute substantially to eating disorder risk. Twin studies estimate heritability for anorexia nervosa in the range of 50 to 80 percent, comparable to heritability estimates for schizophrenia and other serious mental disorders. Genome-wide association studies have begun to identify specific genetic loci associated with anorexia, and the finding that genetic variants associated with anorexia overlap with those associated with physical activity and metabolic traits has been interpreted as suggesting a role for biological mechanisms related to metabolism and energy regulation, rather than purely psychological or social factors. The biological dimension of eating disorders has received growing research attention following decades during which psychological and sociocultural explanations dominated. Neuroimaging research finds differences in brain activation patterns in individuals with eating disorders in circuits related to reward, interoception, and cognitive control. Altered gut-brain communication and the role of the gastrointestinal microbiome in eating disorder pathology are areas of active investigation. These biological findings do not diminish the role of psychological and social factors but suggest that eating disorders involve complex biological-psychological-social interactions rather than purely psychological disturbance. Sociocultural factors, including exposure to idealized thin body images in media, weight stigma in social and medical settings, and cultural messages that link thinness with success and self-worth, are documented risk factors for eating disorders, particularly for the initiation and maintenance of disordered eating behavior. Research on media exposure and body image finds consistent associations between exposure to thin-ideal media and body dissatisfaction, which is a significant risk factor for eating disorder development. However, sociocultural factors alone are insufficient to explain eating disorders, given that most individuals exposed to the same cultural environment do not develop pathological eating behaviors. Treatment for anorexia nervosa remains one of the most challenging problems in psychiatry. No medication has demonstrated consistent efficacy for the core symptoms of anorexia in randomized trials. Psychotherapy approaches including Family-Based Treatment, which mobilizes parents as partners in refeeding adolescents with anorexia, has the strongest evidence base for adolescent populations. Cognitive-behavioral therapy adapted for eating disorders shows more modest effects in adult anorexia. High rates of treatment refusal, relapse, and chronicity mean that even evidence-supported treatments produce less than fully satisfying outcomes in many cases. Treatment for bulimia nervosa and binge eating disorder has a stronger evidence base. Cognitive-behavioral therapy for bulimia nervosa has demonstrated effectiveness in multiple randomized controlled trials, producing significant reductions in binge-purge frequency and improvements in psychological outcomes. Antidepressant medications, particularly fluoxetine, are also supported by evidence for bulimia. For binge eating disorder, CBT and certain antidepressants show effectiveness, and lisdexamfetamine has received FDA approval specifically for binge eating disorder treatment. Disparities in eating disorder research and treatment are significant. The historical focus on thin, white, young women has produced a literature that may not generalize to men, older adults, and people of color, who also develop eating disorders at meaningful rates but receive less research attention and face greater barriers to recognition and treatment. Research using culturally adapted screening and assessment tools finds that eating disorders are present and often undetected in racial and ethnic minority populations, partly because providers may have inaccurate assumptions about who develops these conditions. Early intervention is associated with better outcomes. Research consistently finds that shorter illness duration at treatment entry predicts better treatment response and lower chronicity. This underscores the importance of screening, early identification, and timely access to appropriate care, which are particularly challenging for eating disorders given provider uncertainty about diagnosis and referral and the frequent denial or minimization of symptoms by those affected.